The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-(3,4-dichlorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl)(2,7-diazaspiro[3.5]nonan-2-yl)methanone ID: ALA4745399
PubChem CID: 162647840
Max Phase: Preclinical
Molecular Formula: C20H19Cl2N5O
Molecular Weight: 416.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1nc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CC2(CCNCC2)C1
Standard InChI: InChI=1S/C20H19Cl2N5O/c21-14-4-3-13(10-15(14)22)27-17-16(2-1-7-24-17)25-18(27)19(28)26-11-20(12-26)5-8-23-9-6-20/h1-4,7,10,23H,5-6,8-9,11-12H2
Standard InChI Key: GVURIKUOZVVGMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
23.5789 -21.4905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1661 -22.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5687 -22.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3857 -22.9094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7984 -22.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3942 -21.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0911 -19.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0900 -20.2175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7980 -20.6264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7963 -18.9891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5049 -19.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5097 -20.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2897 -20.4614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7671 -19.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2819 -19.1369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5842 -19.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9970 -20.4967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9887 -19.0814 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5304 -18.3619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3300 -18.1884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5781 -17.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0275 -16.8055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2256 -16.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9813 -17.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2744 -16.0265 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.3765 -17.2363 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
22.7903 -21.2863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7877 -20.7025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
14 16 1 0
16 17 1 0
16 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
15 19 1 0
22 25 1 0
21 26 1 0
17 27 1 0
27 1 1 0
1 28 1 0
28 17 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.31Molecular Weight (Monoisotopic): 415.0967AlogP: 3.55#Rotatable Bonds: 2Polar Surface Area: 63.05Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.02CX LogP: 2.89CX LogD: 0.37Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -1.38
References 1. Vadukoot AK,Sharma S,Aretz CD,Kumar S,Gautam N,Alnouti Y,Aldrich AL,Heim CE,Kielian T,Hopkins CR. (2020) Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors., 11 (10): [PMID:33062163 ] [10.1021/acsmedchemlett.9b00369 ]